Rinvoq induces endoscopic remission in Crohn’s

Rinvoq, an oral selective Janus kinase 1 inhibitor, helped induce endoscopic remission in patients with moderate-to-severe Crohn’s disease, according to study results.Julian Panes, MD, professor of medicine at Hospital Clínic Barcelona, and colleagues wrote that current therapies like corticosteroids and immunosuppressants are not always effective in some patients.“There remains an unmet need for additional targeted therapies for CD that provide short and long-term benefits as measured by both patients’ symptoms and endoscopic outcomes,” they wrote.ResearchersRead More

Share on facebook
Share on twitter
Share on linkedin